KUALA LUMPUR: Malaysian Genomics Resource Centre Bhd (MGRC), which had made a firm debut on the ACE Market on Tuesday, Oct 5 slipped into the red midway during the afternoon session.
At 3.20pm, MGRC fell five sen to RM1.03 with 5.22 million shares traded.
The decline in its share price was in line with overall market breadth, with losers leading gainers by 433 to 250, while 268 counters traded unchanged.
MGRC, which focuses on contract genomics services, raised RM18.47 million for its initial public offering at RM1.08 apiece.
MGRC announced on Monday that it received the approval to implement two genome sequencing and analysis projects from the Malaysian government.
MGRC intends to accept the allocated RM5.97 million, being the first of two tranches.
At 3.20pm, MGRC fell five sen to RM1.03 with 5.22 million shares traded.
The decline in its share price was in line with overall market breadth, with losers leading gainers by 433 to 250, while 268 counters traded unchanged.
MGRC, which focuses on contract genomics services, raised RM18.47 million for its initial public offering at RM1.08 apiece.
MGRC announced on Monday that it received the approval to implement two genome sequencing and analysis projects from the Malaysian government.
MGRC intends to accept the allocated RM5.97 million, being the first of two tranches.
No comments:
Post a Comment